ALX ONCOLOGY HOLDINGS INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-38.4M | $22.1M |
| FY2018 | — | $-51.8M | $8.3M |
| FY2019 | $5.4M | $-70.6M | $9.0M |
| FY2020 | — | $429.8M | $434.2M |
| FY2021 | — | $363.0M | $363.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-38.4M | $22.1M |
| FY2018 | — | $-51.8M | $8.3M |
| FY2019 | $5.4M | $-70.6M | $9.0M |
| FY2020 | — | $429.8M | $434.2M |
| FY2021 | — | $363.0M | $363.7M |